The flavanoide caffeic acid phenethyl ester blocks 6-hydroxydopamine-induced neurotoxicity - PubMed (original) (raw)
Comparative Study
. 2005 Jul;383(1-2):39-43.
doi: 10.1016/j.neulet.2005.04.023.
Affiliations
- PMID: 15894425
- DOI: 10.1016/j.neulet.2005.04.023
Comparative Study
The flavanoide caffeic acid phenethyl ester blocks 6-hydroxydopamine-induced neurotoxicity
Carmen Noelker et al. Neurosci Lett. 2005 Jul.
Abstract
Parkinson's disease (PD) is a neurodegenerative disorder characterized by progressive loss of dopaminergic (DA) neurons of the substantia nigra pars compacta. 6-Hydroxydopamine (6-OHDA) is specific to dopaminergic neurons in intrastriatal rodent models. It induces neuronal death either via uncoupling mitochondrial oxidative phosphorylation resulting in energy deprivation or alternatively, is associated with its ability to produce hydrogen peroxide, hydroxyl and superoxide radicals. Caffeic acid phenethyl ester (CAPE), an antioxidant flavanoid, has antiviral, anti-inflammatory, antioxidant, and immunomodulatory properties. Recent studies have shown that CAPE has also a neuroprotective effects in ischemia and low potassium-induced neuronal apoptotic models. In cerebellar granule neurons CAPE significantly blocks 6-OHDA mediated cell death (70 microM) in a dose-dependent manner. Furthermore, CAPE was able to modulate the Ca(2+)-induced release of cyctochrome c in isolated liver mitochondria. Caspase-3 activation following 6-OHDA treatment was markedly inhibited in the presence of CAPE. Although the molecular mechanisms associated with CAPE's neuroprotective effects remain to be elucidated in more detail, our results clearly demonstrate a considerable neuroprotective effect of CAPE. Since a mitochondrial insult is a major cause for the degeneration of nigral neurons in PD, we hypothesize that propolis derivatives, in particular CAPE, may have a neuroprotective effect on those cells and may be a promising drug candidate to be taken into in vivo models of PD.
Similar articles
- Caffeic acid phenethyl ester prevents cerebellar granule neurons (CGNs) against glutamate-induced neurotoxicity.
Wei X, Ma Z, Fontanilla CV, Zhao L, Xu ZC, Taggliabraci V, Johnstone BH, Dodel RC, Farlow MR, Du Y. Wei X, et al. Neuroscience. 2008 Sep 9;155(4):1098-105. doi: 10.1016/j.neuroscience.2008.06.056. Epub 2008 Jul 3. Neuroscience. 2008. PMID: 18657598 - Caffeic acid phenethyl ester protects against the dopaminergic neuronal loss induced by 6-hydroxydopamine in rats.
Barros Silva R, Santos NA, Martins NM, Ferreira DA, Barbosa F Jr, Oliveira Souza VC, Kinoshita A, Baffa O, Del-Bel E, Santos AC. Barros Silva R, et al. Neuroscience. 2013 Mar 13;233:86-94. doi: 10.1016/j.neuroscience.2012.12.041. Epub 2013 Jan 3. Neuroscience. 2013. PMID: 23291456 - Caffeic acid phenethyl ester blocks free radical generation and 6-hydroxydopamine-induced neurotoxicity.
Ma Z, Wei X, Fontanilla C, Noelker C, Dodel R, Hampel H, Du Y. Ma Z, et al. Life Sci. 2006 Aug 22;79(13):1307-11. doi: 10.1016/j.lfs.2006.03.050. Epub 2006 Apr 26. Life Sci. 2006. PMID: 16707141 - CAPE and Neuroprotection: A Review.
Balaha M, De Filippis B, Cataldi A, di Giacomo V. Balaha M, et al. Biomolecules. 2021 Jan 28;11(2):176. doi: 10.3390/biom11020176. Biomolecules. 2021. PMID: 33525407 Free PMC article. Review.
Cited by
- Mini-encyclopedia of mitochondria-relevant nutraceuticals protecting health in primary and secondary care-clinically relevant 3PM innovation.
Golubnitschaja O, Kapinova A, Sargheini N, Bojkova B, Kapalla M, Heinrich L, Gkika E, Kubatka P. Golubnitschaja O, et al. EPMA J. 2024 Apr 18;15(2):163-205. doi: 10.1007/s13167-024-00358-4. eCollection 2024 Jun. EPMA J. 2024. PMID: 38841620 Free PMC article. - Propolis and Their Active Constituents for Chronic Diseases.
Chavda VP, Chaudhari AZ, Teli D, Balar P, Vora L. Chavda VP, et al. Biomedicines. 2023 Jan 18;11(2):259. doi: 10.3390/biomedicines11020259. Biomedicines. 2023. PMID: 36830794 Free PMC article. Review. - Propolis induces cardiac metabolism changes in 6-hydroxydopamine animal model: A dietary intervention as a potential cardioprotective approach in Parkinson's disease.
Goncalves VC, Silva da Fonsêca V, de Paula Faria D, Izidoro MA, Berretta AA, de Almeida AG, Affonso Fonseca FL, Scorza FA, Scorza CA. Goncalves VC, et al. Front Pharmacol. 2022 Oct 13;13:1013703. doi: 10.3389/fphar.2022.1013703. eCollection 2022. Front Pharmacol. 2022. PMID: 36313332 Free PMC article. - Propolis: Its Role and Efficacy in Human Health and Diseases.
Zullkiflee N, Taha H, Usman A. Zullkiflee N, et al. Molecules. 2022 Sep 19;27(18):6120. doi: 10.3390/molecules27186120. Molecules. 2022. PMID: 36144852 Free PMC article. Review. - Neuroprotective Effect of Intrastriatal Caffeic Acid Phenethyl Ester Treatment in 6-OH Dopamine Model of Parkinson's Disease in Rats.
Soner BC, Acikgoz E, Inan SY, Ayla S, Sahin AS, Oktem G. Soner BC, et al. Parkinsons Dis. 2021 Aug 30;2021:5553480. doi: 10.1155/2021/5553480. eCollection 2021. Parkinsons Dis. 2021. PMID: 34512945 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous